Methylmalonic aciduria (cblF): Case report and response to therapy
Darrel Waggoner, Kosei Ueda, Claudia La Mantia, S. Bruce Dowton
Abstract
Darrel Waggoner, Kosei Ueda, Claudia La Mantia, S. Bruce Dowton
Abstract
Methylmalonic acidemia can be secondary to a deficiency of methylmalonyl CoA mutase or to a defect of cobalamin metabolism that is classified by complementation group. We report on a new patient with cblF complementation group that is associated with an elevation of both methylmalonic acid and homocysteine, and her outcome in response to routine therapy and a dietary restriction.
OpenAlex reports 17 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Methylmalonic acidemia can be secondary to a deficiency of methylmalonyl CoA mutase or to a defect of cobalamin metabolism that is classified by complementation group. We report on a new patient with cblF complementation group that is associated with an elevation of both methylmalonic acid and homocysteine, and her outcome in response to routine therapy and a dietary restriction.
Key concepts: Methylmalonic acid, Methylmalonic aciduria, Cobalamin, Methylmalonic acidemia, Mutase, Complementation, Homocysteine, Internal medicine